Dr. Bashar Samir Alasad - NPI #1215988803

Hematologist & Oncologist located in Oklahoma City, OK

Oklahoma Oklahoma City Hematology & Oncology Dr. Bashar Samir Alasad Information


Dr. Bashar Samir Alasad is a male Hematologist & Oncologist (taxonomy code 207RH0003X) located in Oklahoma City, Oklahoma. Dr. Bashar Samir Alasad's NPI Number is #1215988803 and has been listed in the NPI registry for 10 years. Dr. Bashar Samir Alasad's practice location is listed as: 4301 S Western Ave Oklahoma City, OK 73109-3411 and can be reached via phone at (405) 631-0919.

Hematology & Oncology Taxonomy

The taxonomy code for Dr. Bashar Samir Alasad's main specialty, Hematology & Oncology, is 207RH0003X. An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.



Be the first to rate Dr. Alasad

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1215988803
 Phone (405) 631-0919
 Fax (405) 636-0518
4301 S Western Ave
Oklahoma City, OK 73109-3411
 Gender M
 Website Not provided
  • Hematology & Oncology (OK)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 6/18/2014
 Added 5/16/2006
 Viewed on 10/21/2016
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.